Clinical Trial: A Study of the Safety, Tolerability, and Pharmacokinetics of NYR-BI03 in Healthy Participants
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: A Phase I, Double-Blind, Placebo-Controlled, Randomised, First in Human, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of NYR-BI03 in Healthy Participants, When Admini
Brief Summary:
The goal of this clinical trial is to learn if investigational drug NYR-BI03 is safe and tolerated when given as an intravenous infusion for up to 6 hours to healthy male and female volunteers.The study will also show what if any medical problems participants have when taking drug NYR-BI03 and it will provide information on blood levels of the drug.Researchers will compare drug NYR-BI03 to a placebo (a similar substance that contains no drug) to see if NYR-BI03 is safe and tolerated.Participants will be…
Read more